← Back to Search

Dating Violence Prevention Program for Teen Dating Violence

N/A
Waitlist Available
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
adolescent is between 12 and 15 years old
adolescent identifies as male
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, 12, 18, 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test an online program to help improve emotion regulation and communication between parents and sons to reduce the risk of dating violence and aggressive attitudes.

Who is the study for?
This trial is for boys aged 12-15 who are in the 7th or 8th grade at a participating school, identify as male, and live with their parent/guardian over half the time. Both must speak English or Spanish and agree to join the study. Boys with reading difficulties below a 4th-grade level or developmental delays, or those from households previously involved in the study cannot participate.
What is being tested?
The trial is testing Project STRONG, a web-based program aimed at improving emotion control and communication between sons and parents to reduce boys' risk of engaging in dating violence and changing attitudes that support aggressive behavior.
What are the potential side effects?
Since this intervention involves education and skill development without medical treatments, there are no direct physical side effects expected. However, participants may experience emotional discomfort discussing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 15 years old.
Select...
I identify as male.
Select...
I am between 12 and 15 years old.
Select...
I am a 7th or 8th grader at a participating school.
Select...
I identify as male.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, 12, 18, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 12, 18, 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in dating violence perpetration and victimization from baseline to 24-months
Secondary study objectives
Change in aggressive behavior from baseline to 24 months
Change in attitudes about relationship violence from baseline to 24 months
Change in digital abuse behaviors from baseline to 24 months
+1 more
Other study objectives
Change in bullying behaviors from baseline to 24 months
Change in frequency of sexual and substance use behaviors from baseline to 24 months
School discipline actions from baseline to 24 months

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Project STRONGExperimental Treatment1 Intervention
Project STRONG is an active skill-based intervention designed to prevent adolescent dating violence among middle school boys. Boys and a parent will complete the web-based program together focusing on improving communication and emotion regulation.
Group II: Health PromotionActive Control1 Intervention
Health Promotion is an information-based program designed to mimic content areas provided during middle-school health education. The content is provided via a web-based interface to mirror the content delivery in the active intervention (Project STRONG).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Project STRONG
2015
N/A
~120

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
265 Previous Clinical Trials
68,488 Total Patients Enrolled

Media Library

Health Promotion Clinical Trial Eligibility Overview. Trial Name: NCT04312867 — N/A
Teen Dating Violence Research Study Groups: Project STRONG, Health Promotion
Teen Dating Violence Clinical Trial 2023: Health Promotion Highlights & Side Effects. Trial Name: NCT04312867 — N/A
Health Promotion 2023 Treatment Timeline for Medical Study. Trial Name: NCT04312867 — N/A
~15 spots leftby Apr 2025